Clinical Trials Directory

Trials / Sponsors / Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.

Academic / Other · 9 registered clinical trials — 3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingReVeRA-301: Etripamil in Atrial Fibrillation Phase 3
Atrial Fibrillation
Phase 32027-01-01
RecruitingThe NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
Paroxysmal Supraventricular Tachycardia
Phase 22023-12-11
Enrolling By InvitationEtripamil Nasal Spray in Patients With Paroxysmal Supraventricular Tachycardia
Paroxysmal Supraventricular Tachycardia
Phase 32021-12-13
CompletedReVeRA-201: Etripamil in Atrial Fibrillation, Phase 2
Atrial Fibrillation
Phase 22020-11-19
CompletedSafety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303
Paroxysmal Supraventricular Tachycardia
Phase 32019-09-23
TerminatedSafety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricula
Paroxysmal Supraventricular Tachycardia
Phase 32018-12-10
TerminatedEfficacy and Safety of Etripamil for the Termination of Spontaneous Paroxysmal Supraventricular Tachycardia (P
Paroxysmal Supraventricular Tachycardia
Phase 32018-06-18
TerminatedThe PSVT Place Registry.Paroxysmal Supraventricular Tachycardia (PSVT) Registry.
Paroxysmal Supraventricular Tachycardia (PSVT)
—2017-10-16
CompletedEfficacy and Safety of Intranasal MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm
Paroxysmal Supraventricular Tachycardia (PSVT)
Phase 22015-03-27